Molecular Characterization of Extraocular Muscle

眼外肌的分子表征

基本信息

  • 批准号:
    7251432
  • 负责人:
  • 金额:
    $ 38.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-05-01 至 2009-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The extraocular muscles (EOM) are highly specialized muscles that affect a wide range of motions from the slow vestibulo-ocular reflexes to the rapid saccadic movements. The demands on them are constant, and the responses must be precise. Because the demands on these muscles are distinct from those on other skeletal muscles, it is not surprising that the detailed properties of EOMs are different from those of other muscles. What is surprising - and most important - is that the EOMs have differential sensitivity to certain diseases. EOMs have an increased involvement in disorders such as myasthenia gravis, Grave's disease and mitochondrial myopathies. Enigmatically, they are spared in Duchenne muscular dystrophy, despite the widespread involvement of all other skeletal muscle groups. While it is currently unclear why EOM are selectively involved or spared in different diseases, it has been hypothesized that EOM are a unique set of skeletal muscles and that their 'group-specific' properties play a role in their unique patho-physiology. Consistent with this hypothesis, certain genes (e.g. EOM-specific myosin, certain ACHR subunits) are differentially expressed in EOM compared to other skeletal muscles. This has been confirmed in our laboratory by gene expression profiling comparing EOMs and limb muscles over a small part of the transcriptome. Our central thesis is that EOMs are fundamentally different from other skeletal muscles in their gene expression profile; and that we can trace their unique properties and disease susceptibilities to specific and unique patterns of gene expression. To test these hypotheses we propose: (a) to use gene expression profiling to extend the comparison between EOMs and limb muscles to the entire transcriptome; i.e. beyond the one-third that we have already finished; (b) to use a variety of immunological, molecular, and biochemical methods to validate results of expression profiling and resolve inadequacies and disparities among previous studies; (c) to examine the ability of satellite cells to maintain growth and regeneration in normal mice, in mdx mice, in mdx mice treated with anti myostatin, and in mdx/MyoD knockout mice. This latter set of experiments should validate a major discovery from our previous profiling: that increased regenerative potential is a source of EOM resistance to DMD.
描述(由申请人提供):眼外肌(EOM)是高度专业化的肌肉,影响从缓慢的前庭-眼反射到快速的跳眼运动的广泛运动。对他们的要求是不变的,回应必须是精确的。由于对这些肌肉的需求不同于其他骨骼肌,因此EOMs的详细特性与其他肌肉不同也就不足为奇了。令人惊讶的是——也是最重要的是——eom对某些疾病的敏感度不同。eom在重症肌无力、格雷夫斯病和线粒体肌病等疾病中的作用越来越大。令人费解的是,它们在杜氏肌营养不良症中幸免,尽管所有其他骨骼肌群都广泛参与。虽然目前尚不清楚为什么EOM选择性地参与或不参与不同的疾病,但已经假设EOM是一组独特的骨骼肌,并且它们的“群体特异性”特性在其独特的病理生理学中发挥作用。与这一假设相一致的是,与其他骨骼肌相比,某些基因(例如EOM特异性肌球蛋白,某些ACHR亚基)在EOM中表达差异。我们的实验室通过比较EOMs和肢体肌肉的一小部分转录组的基因表达谱证实了这一点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TEJVIR S KHURANA其他文献

TEJVIR S KHURANA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TEJVIR S KHURANA', 18)}}的其他基金

Development of Utrophin Site Blocking Oligos (SBOs) to Treat Duchenne Muscular Dystrophy (DMD)
开发 Utropin 位点封闭寡核苷酸 (SBO) 来治疗杜氏肌营养不良症 (DMD)
  • 批准号:
    10678195
  • 财政年份:
    2023
  • 资助金额:
    $ 38.48万
  • 项目类别:
Discovery of Post-transcriptional utrophin upregulator small molecules for Duchenne Muscular Dystrophy therapeutics
发现用于杜氏肌营养不良疗法的转录后肌营养不良蛋白上调小分子
  • 批准号:
    9766415
  • 财政年份:
    2017
  • 资助金额:
    $ 38.48万
  • 项目类别:
Preclinical Development of a Novel Therapeutic Strategy for LGMD2B
LGMD2B 新型治疗策略的临床前开发
  • 批准号:
    7895067
  • 财政年份:
    2009
  • 资助金额:
    $ 38.48万
  • 项目类别:
Extraocular muscle stem cells for DMD therapy
眼外肌干细胞用于 DMD 治疗
  • 批准号:
    6953261
  • 财政年份:
    2004
  • 资助金额:
    $ 38.48万
  • 项目类别:
Molecular Characterization of Extraocular Muscle
眼外肌的分子表征
  • 批准号:
    6888029
  • 财政年份:
    2004
  • 资助金额:
    $ 38.48万
  • 项目类别:
Extraocular muscle stem cells for DMD therapy
眼外肌干细胞用于 DMD 治疗
  • 批准号:
    6837929
  • 财政年份:
    2004
  • 资助金额:
    $ 38.48万
  • 项目类别:
Molecular Characterization of Extraocular Muscle (EOM)
眼外肌 (EOM) 的分子表征
  • 批准号:
    7649177
  • 财政年份:
    2004
  • 资助金额:
    $ 38.48万
  • 项目类别:
Molecular Characterization of Extraocular Muscle (EOM)
眼外肌 (EOM) 的分子表征
  • 批准号:
    7896547
  • 财政年份:
    2004
  • 资助金额:
    $ 38.48万
  • 项目类别:
Molecular Characterization of Extraocular Muscle
眼外肌的分子表征
  • 批准号:
    7059921
  • 财政年份:
    2004
  • 资助金额:
    $ 38.48万
  • 项目类别:
Molecular Characterization of Extraocular Muscle
眼外肌的分子表征
  • 批准号:
    7486847
  • 财政年份:
    2004
  • 资助金额:
    $ 38.48万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.48万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 38.48万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 38.48万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 38.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 38.48万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 38.48万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 38.48万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 38.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 38.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 38.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了